Ironwood Pharmaceuticals (IRWD)
(Delayed Data from NSDQ)
$6.84 USD
+0.12 (1.79%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $6.83 -0.01 (-0.15%) 5:24 PM ET
4-Sell of 5 4
C Value B Growth B Momentum B VGM
Price, Consensus and EPS Surprise
IRWD 6.84 +0.12(1.79%)
Will IRWD be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for IRWD based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for IRWD
Implied Volatility Surging for Ironwood Pharmaceuticals (IRWD) Stock Options
New Strong Sell Stocks for July 5th
IRWD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Ironwood (IRWD) Q1 Earnings & Revenues Fall Shy of Estimates
Earnings Preview: Ironwood Pharmaceuticals (IRWD) Q1 Earnings Expected to Decline
OPKO Health (OPK) And Entera Bio Announce Data for GLP-2
Other News for IRWD
Asana, Clover Health Investments, Hertz Global And Other Big Stocks Moving Higher On Friday
Ironwood Pharmaceuticals: Q3 Of 2024 Data Readout For PBC
Ironwood Pharma Elevates CFO and Repays Convertible Notes
Insider Sale: Director Julie Mchugh Sells Shares of Ironwood Pharmaceuticals Inc (IRWD)
Insider Sale: Director Catherine Moukheibir Sells 80,000 Shares of Ironwood Pharmaceuticals Inc ...